oral glp 1 inhibitors Lesson: Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment of Type 2 Diabetes Oral GLP-1 Pills for Weight

Steiger A, Guldner J, Hemmeter U, et al

The study authors said they believe coming off the drug creates a kind of metabolic whiplash. After stopping, the heart benefits seemed to be reversed more quickly than it took to get them in the first place, said study author Dr

doi: 10.3389/fonc.2026.1751474 Received 21 November 2025 Revised 14 January 2026 Accepted 03 February 2026 Published 18 February 2026 Volume 16 - 2026 Edited by Dana Kristjansson, Norwegian Institute of Public Health (NIPH), Norway Reviewed by Feng Wang, Affiliated Hospital of Nantong University, China Bingran Yu, Shandong University, China Updates Copyright 2026 Pathania and Osna

Sold under the brand names Ozempic, Wegovy, and Rybelsus, semaglutide is a prescription medication for type 2 diabetes and long-term weight management

businesses and employees